Citius Oncology (CTOR) Market Capitalization (2022 - 2026)

Citius Oncology (CTOR) has reported Market Capitalization for 5 consecutive years, with $68.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Market Capitalization fell 77.91% year-over-year to $68.7 million in Q2 2026; TTM through Jun 2026 was $68.7 million, a 77.91% decrease from a year earlier, with the FY2025 full-year figure at $169.5 million, up 70.46% from the prior year.
• Market Capitalization was $68.7 million for Q2 2026 at Citius Oncology, up from $57.6 million in the prior quarter.
• Over five years, Market Capitalization peaked at $738.4 million in Q4 2023 and troughed at $32.6 million in Q4 2022.
• A 5-year average of $141.6 million and a median of $84.8 million in 2025 frame the typical range for Market Capitalization.
• Across the five-year window, Market Capitalization soared 2166.19% in 2023 and slumped 88.86% in 2024, its largest moves.
• Over 5 years, Market Capitalization stood at $32.6 million in 2022, then soared by 2166.19% to $738.4 million in 2023, then tumbled by 88.86% to $82.3 million in 2024, then rose by 3.05% to $84.8 million in 2025, then fell by 18.93% to $68.7 million in 2026.
• The last three Market Capitalization figures came in at $68.7 million (Q2 2026), $57.6 million (Q1 2026), and $84.8 million (Q4 2025), per Business Quant data.